Select Page

Study links GLP-1 use in children to nutritional deficiencies

Study links GLP-1 use in children to nutritional deficiencies

Children prescribed GLP-1 medications have increased risk for nutritional deficiencies, according to a recent study from researchers at Ann & Robert H. Lurie Children’s Hospital of Chicago.

The report found that nearly one in six patients prescribed the medication for weight loss, prediabetes or type 2 diabetes were diagnosed with nutritional deficiencies within the first year of using GLP-1s.

Vitamin D deficiency was the most commonly identified deficiency, affecting 12.4 percent of children.

Additionally, researchers found that only 5 percent of patients received any nutritional counseling within 30 days of starting GLP-1 treatment. Less than 25 percent received counseling within the first six months.

“As appropriate pediatric use of GLP-1s becomes more widespread, we need to understand the risks during periods of rapid growth and pubertal development,” said Justin Ryder, the study’s senior author and vice chair of research for the department of surgery at Lurie Children’s. “Nutrients such as vitamin D, iron and calcium are of particular concern during adolescence, when deficiencies may have lasting implications for skeletal health and overall development.”

Researchers used national administrative claims data from 2017 to 2022, covering over 100 million patients, to identify 2,031 GLP-1 users between the ages of 10 and 17 who met continuous enrollment criteria and had no prior diagnosis of nutritional deficiency.

About The Author